Loss of ADAMTS19 causes progressive non-syndromic heart valve disease

Florian Wünnemann(University of Münster), Asaf Ta‐Shma(Hadassah Medical Center), Christoph Preuß(Jackson Laboratory), Séverine Leclerc(Centre Hospitalier Universitaire Sainte-Justine), Patrick van Vliet(Inserm), Andrea Oneglia(Centre Hospitalier Universitaire Sainte-Justine), Maryse Thibeault(Centre Hospitalier Universitaire Sainte-Justine), Emily Nordquist(Medical College of Wisconsin), Joy Lincoln(Children's Hospital of Wisconsin), Franka Scharfenberg(Christian-Albrechts-Universität zu Kiel), Christoph Becker‐Pauly(Christian-Albrechts-Universität zu Kiel), P. Hofmann(University Hospital Schleswig-Holstein), Kirstin Hoff(University Hospital Schleswig-Holstein), Enrique Audain(University Hospital Schleswig-Holstein), Hans-Heiner Kramer(University Hospital Schleswig-Holstein), Wojciech Makałowski(University of Münster), Amiram Nir(Hadassah Medical Center), Sebastian S. Gerety(Wellcome Sanger Institute), Matthew E. Hurles(Wellcome Sanger Institute), Johanna Comes(Centre Hospitalier Universitaire Sainte-Justine), Anne Fournier(Université de Montréal), Hanna Osińska(Cincinnati Children's Hospital Medical Center), Jeffrey Robins(Cincinnati Children's Hospital Medical Center), Michel Pucéat(Inserm), Harry C. Dietz(Johns Hopkins University), Andrew S. McCallion(Johns Hopkins University), Grégor Andelfinger(Centre Hospitalier Universitaire Sainte-Justine), Bart Loeys(University of Antwerp), Lut Van Laer(University of Antwerp), Per Eriksson(Karolinska University Hospital), Salah A. Mohamed, Luc Mertens(Hospital for Sick Children), Anders Franco-Cereceda(Karolinska University Hospital), Seema Mital(University of Toronto), Orly Elpeleg(Hadassah Medical Center), Marc‐Phillip Hitz(Wellcome Sanger Institute), Grégor Andelfinger(Centre Hospitalier Universitaire Sainte-Justine)
Nature Genetics
December 16, 2019
Cited by 64Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis